Virios Therapeutics Stock (NASDAQ: VIRI) stock price, news, charts, stock research, profile.
You can purchase shares of Virios Therapeutics (NASDAQ:VIRI) through any online brokerage.
Other companies in Virios Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), CERo Therapeutics Hldgs (NASDAQ:CERO), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and NuCana (NASDAQ:NCNA).
Virios Therapeutics has a consensus price target of $0.60.
The stock price for Virios Therapeutics (NASDAQ: VIRI) is $0.1564 last updated October 1, 2024 at 5:36 PM EDT.
There are no upcoming dividends for Virios Therapeutics.
Virios Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Virios Therapeutics.
Virios Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.